NCT00770770View on ClinicalTrials.gov

Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina

PHASE2TerminatedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

October 31, 2013

Conditions
Macular EdemaRetinal Vein Occlusion
Interventions
DRUG

Fluocinolone Acetonide

0.2 µg/day

DRUG

Fluocinolone Acetonide

0.5 µg/day

Trial Locations (3)

44195

Cole Eye Institute, Cleveland

Unknown

University of Kentucky Department of Ophthalmology, Lexington

Ophthalmic Consultants of Boston, Boston

Sponsors

Lead Sponsor

Alimera Sciences
All Listed Sponsors
lead

Alimera Sciences

INDUSTRY